| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 04/20/2011 | CN101269143B Method for preparing Fupoganmao particle and prepared product |
| 04/20/2011 | CN101245051B 2,4-di-substituted amido-6-substituted-[1,3,5]triazine or miazines compound, preparation method, pharmaceutical combination and use of the same |
| 04/20/2011 | CN101228262B Novel bacterium belonging to the genus bifidobacterium and utilization of the same |
| 04/20/2011 | CN101195609B Method for producing 5,6-dimethyl xanthenone-4-acetic acid, derivant and pharmaceutical formulation produced with the method |
| 04/20/2011 | CN101185707B Antiphlogistic antiviral medicinal composition, and its preparation method and application |
| 04/20/2011 | CN101066313B Chinese medicine preparation for antagonizing bacteria and viruses of pig and improving pork quality, and its preparation process |
| 04/20/2011 | CN101053614B Flesh and blood healing external applied anti-infectious powder and its medicine preparation |
| 04/20/2011 | CN101049362B External remedy for treating onychomycosis |
| 04/20/2011 | CN101039935B New piperidine antibiotics |
| 04/20/2011 | CN100998637B Traditional Chinese medicine for treating bone tuberculosis and arthritis |
| 04/19/2011 | US7928255 Intermediates for the preparation of lipoxin A4 analogs |
| 04/19/2011 | US7928219 chemically modified nucleic acid molecule; cancer; carcinoma, neovascularization, diabetic retinopathy, neovascular glaucoma, myopic degeneration and other proliferative diseases, restenosis and polycystic kidney disease |
| 04/19/2011 | US7928218 Treatment of any disease that responds to modulation of gene expression, for example cancer, proliferative, inflammatory, metabolic, autoimmune, neurologic, ocular diseases; in vivo stability and bioavailability |
| 04/19/2011 | US7928209 reporter system reflecting the transport process that transports GPI-anchored proteins to the cell wall was constructed and compounds inhibiting this process were discovered; antifungal agents; inhibiting expression of cell wall glycoproteins and preventing pathogens from showing pathogenicity; DNA |
| 04/19/2011 | US7928096 Polydiazeniumdiolated cyclic polyamines with polyphasic nitric oxide release and related compounds, compositions comprising same and methods of using same |
| 04/19/2011 | US7928086 β-L-2′-deoxynucleosides for the treatment of resistant HBV strains and combination therapies |
| 04/19/2011 | US7928073 Purified polypeptides having IL-13 receptor activity |
| 04/19/2011 | US7927858 Drying process |
| 04/19/2011 | US7927793 Cell lines and host nucleic acid sequences related to infectious disease |
| 04/19/2011 | US7927622 Methods of transnasal transport/immunization with highly adaptable carriers |
| 04/19/2011 | US7927609 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 04/19/2011 | US7927606 Modified free-living microbes, vaccine compositions and methods of use thereof |
| 04/19/2011 | US7927605 Diagnosing and preventing microorganismal infections using iron-restricted conditions; genetic vaccines |
| 04/19/2011 | CA2628963C Benzene derivative or salt thereof |
| 04/19/2011 | CA2538546C Polymorphic forms of rifaximin, processes for their production and use thereof in medicinal preparations |
| 04/19/2011 | CA2513081C Pyrrolopyridazine derivatives |
| 04/19/2011 | CA2478081C Multiple and multivalent dna vaccines in ovo |
| 04/19/2011 | CA2476012C Substituted pyridinones as modulators of p38 map kinase |
| 04/19/2011 | CA2450203C Capsular polysaccharide solubilisation and combination vaccines |
| 04/19/2011 | CA2422094C Vaccination method |
| 04/19/2011 | CA2400969C Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response to measles vaccine |
| 04/19/2011 | CA2393802C 3-aminoquinazolin-2,4-dione antibacterial agents |
| 04/19/2011 | CA2378778C Il-16 antagonists |
| 04/19/2011 | CA2320429C Antimicrobial peptides and derived metapeptides |
| 04/19/2011 | CA2282790C Chimeric flavivirus vaccines |
| 04/19/2011 | CA2195090C Lkp pilin structural genes and operon of nontypable haemophilus influenzae |
| 04/19/2011 | CA2189979C Improved modified live brsv vaccine |
| 04/16/2011 | CA2735344A1 A novel formulation for treating fungal infections |
| 04/14/2011 | WO2011044576A2 Selectively disrupted whole-cell vaccine |
| 04/14/2011 | WO2011044570A2 Recombinant antibodies against h1n1 influenza |
| 04/14/2011 | WO2011044538A1 Antibacterial aminoglycoside analogs |
| 04/14/2011 | WO2011044505A2 Enzyme inhibiting compounds and methods |
| 04/14/2011 | WO2011044503A1 Antibacterial aminoglycoside analogs |
| 04/14/2011 | WO2011044502A1 Antibacterial aminoglycoside analogs |
| 04/14/2011 | WO2011044501A2 Antibacterial aminoglycoside analogs |
| 04/14/2011 | WO2011044499A2 Enterotoxigenic e. coli fusion protein vaccines |
| 04/14/2011 | WO2011044498A1 Antibacterial aminoglycoside analogs |
| 04/14/2011 | WO2011044105A1 Treatment with cholinergic agonists |
| 04/14/2011 | WO2011043735A1 A composition for modulating immune responses |
| 04/14/2011 | WO2011043631A2 Pharmaceutical composition for preventing and treating cold, containing reynoutria elliptica extract, fraction thereof or stilbene-based compound |
| 04/14/2011 | WO2011043435A1 Therapeutic agent for influenza virus infectious diseases |
| 04/14/2011 | WO2011043397A1 Anti-influenza virus agent |
| 04/14/2011 | WO2011043371A1 Oxazole compound |
| 04/14/2011 | WO2011042684A2 Antimicrobial composition and method of controlling contamination or infections using said composition |
| 04/14/2011 | WO2010027502A9 Method of inducing an anti-viral immune response |
| 04/14/2011 | WO2001085798A9 Human monoclonal antibodies to dendritic cells |
| 04/14/2011 | US20110088104 Novel antibodies for the treatment of hiv |
| 04/14/2011 | US20110086915 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
| 04/14/2011 | US20110086911 Novel bismuth(iii) nsaid compounds and methods for their use |
| 04/14/2011 | US20110086899 Pharmaceutical compositions for oral administration |
| 04/14/2011 | US20110086893 Oxa- and thiadiazoles and their use as metalloproteinase inhibitors |
| 04/14/2011 | US20110086883 Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms) |
| 04/14/2011 | US20110086879 Carboxamide compounds and their use as calpain inhibitors |
| 04/14/2011 | US20110086877 Small Molecule Inhibitors of Botulinum Neurotoxins |
| 04/14/2011 | US20110086871 Rifaximin compositions and method of use |
| 04/14/2011 | US20110086869 Methods for treating viral disorders |
| 04/14/2011 | US20110086867 6-(c2-6alkylseleno)purines and methods for treating neural measles viral infection therewith |
| 04/14/2011 | US20110086858 Compounds for the Treatment of Hepatitis C |
| 04/14/2011 | US20110086857 N-((1r,2s,5r)-5-(tert-butylamino)-2-((s)-3-(7-tert-butylpyrazolo[1,5-a][1,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide, a dual modulator of chemokine receptor activity, crystalline forms and processes |
| 04/14/2011 | US20110086856 Compositions useful as inhibitors of protein kinases |
| 04/14/2011 | US20110086843 Thiazole Derivatives and Use Thereof |
| 04/14/2011 | US20110086842 Pyrimidines as PLK inhibitors |
| 04/14/2011 | US20110086835 Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as janus kinase inhibitors |
| 04/14/2011 | US20110086831 Procalcitonin for the diagnosis of bacterial infections and guidance of antibiotic treatment in patients with acute stroke or transient ischemic attack |
| 04/14/2011 | US20110086822 Substituted Tetracycline Compounds |
| 04/14/2011 | US20110086817 Anti-bacterial agents from benzo[d]heterocyclic scaffolds for prevention and treatment of multidrug resistant bacteria |
| 04/14/2011 | US20110086815 Novel compositions containing xanthohumol-cyclodextrin complexes |
| 04/14/2011 | US20110086814 Inhibiting e.sakazakii growth |
| 04/14/2011 | US20110086813 Compounds for treating bacterial infections |
| 04/14/2011 | US20110086812 Transition state sturcture of 5'-methylthioadenosine/s-adenosylhomocysteine nucleosidases |
| 04/14/2011 | US20110086810 HYDROXYL, KETO, AND GLUCURONIDE DERIVATIVES OF 3-(4-(7H-PYRROLO[2,3-d] PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYLPROPANENITRILE |
| 04/14/2011 | US20110086797 Control of spore germination |
| 04/14/2011 | US20110086118 Composition for prevention of influenza viral infection comprising sumac extract, air filter comprising the same and air cleaning device comprising the filter |
| 04/14/2011 | US20110086117 Antiseptic treat dip microemulsion |
| 04/14/2011 | US20110086101 Dispersinb, 5-Fluorouracil, Deoxyribonuclease I and Proteinase K-Based Antibiofilm Compositions and Uses Thereof |
| 04/14/2011 | US20110086071 Pharmaceutical Compositions Comprising Terbinafine |
| 04/14/2011 | US20110086065 Lentival Vector-Based Vaccine |
| 04/14/2011 | US20110086062 Alphavirus replicon particles matched to protein antigens as immunological adjuvants |
| 04/14/2011 | US20110086059 Non-hemolytic clya for excretion of proteins |
| 04/14/2011 | US20110086058 Immunopotentiator-Linked Oligomeric Influenza Immunogenic Compositions |
| 04/14/2011 | US20110086057 OX40R Binding Agents |
| 04/14/2011 | US20110086052 Activation of innate and adaptive immune responses by a ginseng extract |
| 04/14/2011 | US20110086050 Glycoprotein compositions |
| 04/14/2011 | US20110086048 Detection of human immunodeficiency virus co-receptor tropism in aviremic subjects |
| 04/14/2011 | US20110086046 Treatment of MS with goat serum |
| 04/14/2011 | US20110086041 Fusion-Intermediate State of HIV-1 gP41 Targeted by Broadly Neutralizing Antibodies |
| 04/14/2011 | US20110086035 Immunotherapeutic methods and molecules |
| 04/14/2011 | US20110086028 Prevention of hiv infection |
| 04/14/2011 | US20110086024 Use of antagonists of the interaction between hiv gp120 and a4b7 integrin |
| 04/14/2011 | US20110086016 Enzymatic pre-mixture against Gram negative bacteria colonization in the animal intestinal tract |